These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 24384139)

  • 41. Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA.
    Javid H; Rahimian R; Salimi M; Haghani-Samani E; Farhadi M; Torkaman-Boutorabi A
    Mol Biol Rep; 2024 Jun; 51(1):768. PubMed ID: 38884894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
    Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
    Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.
    Morroni F; Sita G; Tarozzi A; Cantelli-Forti G; Hrelia P
    Brain Res; 2014 Nov; 1589():93-104. PubMed ID: 25257035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
    Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF
    Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
    Cui Q; Li X; Zhu H
    Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease.
    Zhu G; Chen G; Shi L; Feng J; Wang Y; Ye C; Feng W; Niu J; Huang Z
    Mol Neurobiol; 2015 Feb; 51(1):32-42. PubMed ID: 24930088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
    Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
    Decressac M; Pain S; Chabeauti PY; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A
    Neurobiol Aging; 2012 Sep; 33(9):2125-37. PubMed ID: 21816512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. JWH133 attenuates behavior deficits and iron accumulation in 6-OHDA-induced Parkinson's disease model rats.
    Liu M; Pan D; Wang M; Deng H; Ma Z
    J Neurophysiol; 2024 Sep; 132(3):733-743. PubMed ID: 39015077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A New Danshensu Derivative Protects Against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro and In Vivo.
    Cui G; Shan L; Chen Y; Zhou H; Wang Y; Lee SM
    Am J Chin Med; 2016; 44(7):1349-1361. PubMed ID: 27785944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
    Yan J; Yang Z; Zhao N; Li Z; Cao X
    BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
    Ge H; Yan Z; Zhu H; Zhao H
    Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease.
    Jia Y; Mo SJ; Feng QQ; Zhan ML; OuYang LS; Chen JC; Ma YX; Wu JJ; Lei WL
    J Mol Neurosci; 2014 May; 53(1):117-24. PubMed ID: 24390959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
    Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
    Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
    Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
    J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
    Front Immunol; 2021; 12():794770. PubMed ID: 34925379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Huang W; Wang Y; Huang W
    Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.